Literature DB >> 18004585

Transplantation of cells from eye-like structures differentiated from embryonic stem cells in vitro and in vivo regeneration of retinal ganglion-like cells.

Hitomi Aoki1, Akira Hara, Masayuki Niwa, Tsutomu Motohashi, Takashi Suzuki, Takahiro Kunisada.   

Abstract

BACKGROUND: An embryonic stem (ES) cell-derived eye-like structure, made up of neural retinal lineage cells, retinal pigment epithelial (RPE) cells, and lens cells was constructed in our laboratory. We have shown that cells from these eye-like structures can be integrated into the developing optic vesicle of chicks. The purpose of this study was to determine whether the cells from these eye-like structures can differentiate into retinal ganglion cells (RGCs) when transplanted into the vitreous of an injured adult mouse retina.
METHODS: ES cells were induced to differentiate into eye-like structures in vitro for 6 or 11 days. Recipient mouse eyes were injected with NMDA to injure the RGCs prior to the transplantation. Sham-treated eyes received the same amount of carrier vehicle. Cells were extracted from the eye-like structures and transplanted into the vitreous of damaged and control eyes. The host eyes were analyzed both qualitatively and quantitatively by immunohistochemistry 10 days or 8 weeks after transplantation.
RESULTS: Cells from the ES cell-derived eye-like structures were integrated into the RGC layer, and differentiated into neurons when transplanted into control (non-NMDA-treated) adult eyes. However, they rarely expressed RGC markers. When they were transplanted into NMDA-treated eyes, the cells spread on the surface of the retina and covered a relatively large area of the host RGC layer that had been injured by the NMDA. The cells from the ES cell-derived eye cells frequently differentiated into cells expressing RGC-specific markers, and formed a new RGC layer. In addition, a small number of these ES cell-derived cells were observed to extend axon-like processes toward the optic disc of the host. However, visually evoked responses could not be recorded from the visual cortex. DISCUSSION: These findings suggest that ES cell-derived eye-like structures contain cells that can differentiate into RG-like cells and regenerate a new RGC layer. These cells also appeared to be integrated into the retina and extend axon-like processes toward the optic nerve head.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18004585     DOI: 10.1007/s00417-007-0710-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  23 in total

1.  Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity.

Authors:  Hiroshi Kawasaki; Hirofumi Suemori; Kenji Mizuseki; Kiichi Watanabe; Fumi Urano; Hiroshi Ichinose; Masatoshi Haruta; Masayo Takahashi; Kanako Yoshikawa; Shin-Ichi Nishikawa; Norio Nakatsuji; Yoshiki Sasai
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

2.  Generation of structures formed by lens and retinal cells differentiating from embryonic stem cells.

Authors:  Mariko Hirano; Akitsugu Yamamoto; Naoko Yoshimura; Tomoyuki Tokunaga; Tsutomu Motohashi; Katsuhiko Ishizaki; Hisahiro Yoshida; Kenji Okazaki; Hidetoshi Yamazaki; Shin-Ichi Hayashi; Takahiro Kunisada
Journal:  Dev Dyn       Date:  2003-12       Impact factor: 3.780

3.  Subretinal injections in rodent eyes: effects on electrophysiology and histology of rat retina.

Authors:  A M Timmers; H Zhang; A Squitieri; C Gonzalez-Pola
Journal:  Mol Vis       Date:  2001-06-22       Impact factor: 2.367

4.  Widespread integration and survival of adult-derived neural progenitor cells in the developing optic retina.

Authors:  M Takahashi; T D Palmer; J Takahashi; F H Gage
Journal:  Mol Cell Neurosci       Date:  1998-12       Impact factor: 4.314

5.  Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord.

Authors:  J W McDonald; X Z Liu; Y Qu; S Liu; S K Mickey; D Turetsky; D I Gottlieb; D W Choi
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

6.  An in vitro mouse model for retinal ganglion cell replacement therapy using eye-like structures differentiated from ES cells.

Authors:  Hitomi Aoki; Akira Hara; Masayuki Niwa; Tsutomu Motohashi; Takashi Suzuki; Takahiro Kunisada
Journal:  Exp Eye Res       Date:  2007-01-27       Impact factor: 3.467

7.  Wnt2b controls retinal cell differentiation at the ciliary marginal zone.

Authors:  Fumi Kubo; Masatoshi Takeichi; Shinichi Nakagawa
Journal:  Development       Date:  2003-02       Impact factor: 6.868

8.  Embryonic stem cells are capable of generating a neuronal network in the adult mouse retina.

Authors:  Akira Hara; Masayuki Niwa; Takahiro Kunisada; Naoko Yoshimura; Masaki Katayama; Osamu Kozawa; Hideki Mori
Journal:  Brain Res       Date:  2004-03-05       Impact factor: 3.252

9.  Fragmented DNA transport in dendrites of retinal neurons during apoptotic cell death.

Authors:  Akira Hara; Masayuki Niwa; Masako Kumada; Nami Kitaori; Tetsuya Yamamoto; Osamu Kozawa; Hideki Mori
Journal:  Brain Res       Date:  2004-05-08       Impact factor: 3.252

10.  Neural differentiation of mouse embryonic stem cells in vitro and after transplantation into eyes of mutant mice with rapid retinal degeneration.

Authors:  Jason S Meyer; Martin L Katz; Joel A Maruniak; Mark D Kirk
Journal:  Brain Res       Date:  2004-07-16       Impact factor: 3.252

View more
  22 in total

Review 1.  Lens fibre cell differentiation and organelle loss: many paths lead to clarity.

Authors:  Michael A Wride
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-04-27       Impact factor: 6.237

Review 2.  Mobilizing endogenous stem cells for retinal repair.

Authors:  Honghua Yu; Thi Hong Khanh Vu; Kin-Sang Cho; Chenying Guo; Dong Feng Chen
Journal:  Transl Res       Date:  2013-11-22       Impact factor: 7.012

3.  Methods of Retinal Ganglion Cell Differentiation From Pluripotent Stem Cells.

Authors:  Katherine P Gill; Alex W Hewitt; Kathryn C Davidson; Alice Pébay; Raymond C B Wong
Journal:  Transl Vis Sci Technol       Date:  2014-07-01       Impact factor: 3.283

4.  Transplantation of reprogrammed embryonic stem cells improves visual function in a mouse model for retinitis pigmentosa.

Authors:  Nan-Kai Wang; Joaquin Tosi; Jennifer Mie Kasanuki; Chai Lin Chou; Jian Kong; Nancy Parmalee; Katherine J Wert; Rando Allikmets; Chi-Chun Lai; Chung-Liang Chien; Takayuki Nagasaki; Chyuan-Sheng Lin; Stephen H Tsang
Journal:  Transplantation       Date:  2010-04-27       Impact factor: 4.939

5.  Scaffolds and stem cells: delivery of cell transplants for retinal degenerations.

Authors:  Karl E Kador; Jeffrey L Goldberg
Journal:  Expert Rev Ophthalmol       Date:  2012-10-01

6.  Tissue engineering the retinal ganglion cell nerve fiber layer.

Authors:  Karl E Kador; Ramon B Montero; Praseeda Venugopalan; Jonathan Hertz; Allison N Zindell; Daniel A Valenzuela; Mohammed S Uddin; Erin B Lavik; Kenneth J Muller; Fotios M Andreopoulos; Jeffrey L Goldberg
Journal:  Biomaterials       Date:  2013-03-11       Impact factor: 12.479

Review 7.  Retinal repair with induced pluripotent stem cells.

Authors:  Shomoukh Al-Shamekh; Jeffrey L Goldberg
Journal:  Transl Res       Date:  2013-11-08       Impact factor: 7.012

Review 8.  Retinal Tissue Bioengineering, Materials and Methods for the Treatment of Glaucoma.

Authors:  Sanaz Behtaj; Andreas Öchsner; Yuri G Anissimov; Maksym Rybachuk
Journal:  Tissue Eng Regen Med       Date:  2020-05-10       Impact factor: 4.169

Review 9.  Stem cells, retinal ganglion cells and glaucoma.

Authors:  Valentin M Sluch; Donald J Zack
Journal:  Dev Ophthalmol       Date:  2014-04-10

10.  Retinal ganglion cell polarization using immobilized guidance cues on a tissue-engineered scaffold.

Authors:  Karl E Kador; Haneen S Alsehli; Allison N Zindell; Lung W Lau; Fotios M Andreopoulos; Brant D Watson; Jeffrey L Goldberg
Journal:  Acta Biomater       Date:  2014-09-04       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.